Medtronic received information that during its positioning, this transcatheter bioprosthetic valve was deployed too high and moved from its targeted position.As the valve was being withdrawn, the tension created by the patient¿s ascending aortic arch against the delivery catheter system (dcs) opened the dcs capsule far enough for the valve¿s frame loops to release from the dcs tabs.The valve was deployed in the ascending aorta.A second valve was then successfully implanted.The physician reported that the malposition of the first valve was the result of the deployment attempt being initiated too high in the annulus.No adverse patient effects were reported.
|
Conclusion: the reported clinical observation does not indicate a potential manufacturing issue.Potential factors that can influence a valve dislodgement include tension applied on the delivery catheter system (dcs) during positioning, calcification levels and compliance of the native anatomy, and a number of others.It should be noted that dislodgement complaints are typically not related to a device malfunction.This event does not allege a device malfunction occurred.In this case, during the implant of this transcatheter bioprosthetic valve, the valve was deployed too high and dislodged when at two-thirds deployment.Per the physician, deployment of the first valve had been initiated too high in the annulus.However, a conclusive root cause of the dislodgement could not be established from the information available.Per corevalve instructions for use (ifu), ¿once deployment is initiated, retrieval of the bioprosthesis from the patient (e.G., use of the catheter) is not recommended.Retrieval of a partially deployed valve using the catheter may cause mechanical failure of the delivery catheter system, aortic root damage, coronary artery damage, myocardial damage, vascular complications, prosthetic valve dysfunction (including device malposition), embolization, stroke, and/or emergent surgery.¿.
|